+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Hyperfine

HYPRNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.20

0.1413.21%

At Close: -

$1.20

00.00%

After Hours: 7:33 PM EDT

15 minutes delayed

Hyperfine (HYPR) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Hyperfine (NASDAQ:HYPR) Stock

Hyperfine Stock (NASDAQ: HYPR)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, July 15, 2024

Hyperfine's Portable MRI As Tissue Clock For ...
Benzinga Newsdesk

Tuesday, June 25, 2024

Hyperfine's Clinical Research Using Swoop Sys...
Benzinga Newsdesk

Tuesday, May 28, 2024

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Zacks
Hyperfine Enters Distribution Partnership Wit...
Benzinga Newsdesk

Monday, May 13, 2024

Hyperfine Expects FY24 Revenue To Be $12M-$15...
Benzinga Newsdesk
Hyperfine Q1 2024 GAAP EPS $(0.14) Beats $(0....
Benzinga Newsdesk

Friday, May 10, 2024

Hyperfine Enters Agreements With Distributors...
Benzinga Newsdesk

Tuesday, April 23, 2024

Hyperfine Announced The Acceptance Of Sevente...
Benzinga Newsdesk

Wednesday, April 17, 2024

Hyperfine Enrolls First Alzheimer's Patients ...
Benzinga Newsdesk

Thursday, March 21, 2024

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Recap: Hyperfine Q4 Earnings
Benzinga Insights
Hyperfine Q4 EPS $(0.15) Beats $(0.18) Estima...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights

Wednesday, March 20, 2024

Hyperfine Earnings Preview
Benzinga Insights

Wednesday, February 21, 2024

Hyperfine, Inc. Announces Collaboration With ...
Benzinga Newsdesk

Friday, January 12, 2024

Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Tuesday, January 09, 2024

Hyperfine Launches AI-Powered Brain Imaging S...
Benzinga Newsdesk

Thursday, November 30, 2023

Jefferies Initiates Coverage On Hyperfine wit...
Benzinga Newsdesk

Monday, November 20, 2023

Hyperfine, Inc. Announces Presentations On Cl...
Benzinga Newsdesk

Friday, November 10, 2023

Hyperfine shares are trading lower after the ...
Benzinga Newsdesk

Thursday, November 09, 2023

Hyperfine Expects FY23 Revenue $11M-$13M
Benzinga Newsdesk
Recap: Hyperfine Q3 Earnings
Benzinga Insights
Hyperfine Q3 2023 Gaap EPS $(0.15) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights

Thursday, November 02, 2023

Observational Study Finds That Hyperfine Port...
Benzinga Newsdesk

Monday, October 09, 2023

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Hyperfine, Inc. Receives FDA Clearance For Up...
Bill Haddad

Wednesday, September 06, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Tuesday, August 15, 2023

B. Riley Securities Maintains Buy on Hyperfin...
Benzinga Newsdesk

Monday, August 14, 2023

Hyperfine Q2 EPS $(0.15) Beats $(0.16) Estima...
Benzinga Newsdesk
Earnings Scheduled For August 14, 2023
Benzinga Insights

Tuesday, July 25, 2023

Chief Operating Officer at Hyperfine Acquires Company Stock Options Worth 200,000 Shares
Benzinga Insights

Wednesday, July 19, 2023

Hyperfine Has Received A Decision To Grant European Patent Number EP3837636 Titled "Deep Learning Techniques For Suppressing Artefacts In Magnetic Resonance Images".
Happy Mohamed

Tuesday, July 18, 2023

Hyperfine Announces Promotion of Tom Teisseyr...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Tuesday, July 04, 2023

Hyperfine Board Member Awarded $427K Worth of Stock Options
Benzinga Insights
Hyperfine Director Awarded $427K Worth of Stock Options
Benzinga Insights

Thursday, May 18, 2023

Hyperfine, Inc. Receives Grant For An Additional 3-Years To Utilize Innovative Swoop Portable MR Imaging System In Low And Middle-Income Countries; Covered Under New $3M Grant
Happy Mohamed

Thursday, May 11, 2023

Recap: Hyperfine Q1 Earnings
Benzinga Insights
Hyperfine Q1 EPS $(0.17) Misses $(0.13) Estim...
Benzinga Newsdesk
Earnings Scheduled For May 11, 2023
Benzinga Insights

Wednesday, March 22, 2023

B. Riley Securities Maintains Buy on Hyperfin...
Benzinga Newsdesk

Tuesday, March 21, 2023

Hyperfine Q4 EPS $(0.19) Beats $(0.22) Estimate, Sales $1.42M Miss $2.25M Estimate
Happy Mohamed
Earnings Scheduled For March 21, 2023
Benzinga Insights

Monday, March 20, 2023

Hyperfine's Earnings: A Preview
Benzinga Insights

Monday, March 13, 2023

Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Lisa Levin

Tuesday, February 28, 2023

Hyperfine, Inc. Receives FDA Clearance For Updated Software To Further Improve Diffusion-Weighted Imaging
Happy Mohamed

Monday, February 27, 2023

Hyperfine Has Been Granted FDA 510k Clearance For The Swoop Portable MR Imaging System
Happy Mohamed

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved